Primary Glioblastoma Multiforme: Clinical Trials

2 trials for Primary Glioblastoma Multiforme, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Terminated 1

Follow Primary Glioblastoma Multiforme: new trials by email Literature Review of Primary Glioblastoma Multiforme trials Research Report on Primary Glioblastoma Multiforme

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Radiation Therapy, AZD1390 - Recurrent Glioblastoma Multiforme, Primary Glioblastoma Multiforme
Phase 1CompletedAstraZeneca1592018-04-022026-10-15
Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme
Gliadel Wafer, Temodar and Radiotherapy - Primary Glioblastoma Multiforme
Phase 2TerminatedUniversity of Iowa502005-10-012016-10-27

Narrower conditions

Brain Neoplasms (1)  ·  Glioblastoma (1)  ·  Hereditary Sensory and Autonomic Neuropathies (1)  ·  Inhibition, Psychological (1)  ·  Meningeal Neoplasms (1)

Broader conditions

Astrocytoma (1)  ·  Behavior (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Glioma (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)

Interventions

Radiotherapy (2)  ·  AZD1390 (1)  ·  Carmustine (1)  ·  Temozolomide (1)

Sponsors

AstraZeneca (1)  ·  University of Iowa (1)

Countries

United States (2)  ·  Japan (1)  ·  United Kingdom (1)

Top investigators

Anthony Chalmers (1)  ·  Brandon Imber (1)  ·  Deborah Forst (1)  ·  Jan Drappatz (1)  ·  Kazuhiko Mishima (1)  ·  Louise Murray (1)  ·  Mariza Daras (1)  ·  Patrick Wen (1)  ·  Rajesh Jena (1)  ·  Timothy Ryken, MD (1)  ·  Yoshiki Arakawa (1)  ·  Yoshitaka Narita (1)

NIH funding

2017 (1)